Insights into the Assessment of Measurable Residual Disease (MRD) in Patients With Multiple Myeloma

被引:0
|
作者
Costa, Luciano J. [1 ,2 ,3 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Med, ONeal Comprehens Canc Ctr Clin Trials Off, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Sch Med, Hematol Malignancies Working Grp, Hematol & Oncol, Birmingham, AL 35294 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [41] Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
    Tembhare, Prashant R.
    Sriram, Harshini
    Khanka, Twinkle
    Gawai, Sanghamitra
    Bagal, Bhausaheb
    Ghogale, Sitaram G.
    Deshpande, Nilesh
    Girase, Karishma
    Patil, Jagruti
    Hasan, Syed Khaizer
    Shetty, Dhanalaxmi
    Ghosh, Kinjalka
    Chatterjee, Gaurav
    Rajpal, Sweta
    Patkar, Nikhil V.
    Jain, Hasmukh
    Punatar, Sachin
    Gokarn, Anant
    Nayak, Lingaraj
    Mirgh, Sumeet
    Jindal, Nishant
    Sengar, Manju
    Khattry, Navin
    Subramanian, Papagudi G.
    Gujral, Sumeet
    HEMASPHERE, 2024, 8 (04):
  • [42] Minimal residual disease (MRD) investigation in multiple myeloma - hype or real progress?
    Hose, D.
    Seckinger, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 244 - 245
  • [43] Genomic Landscape Predictive of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)
    Samur, Mehmet K.
    Minvielle, Stephane
    Magrangeas, Florence
    Parmigiani, Giovanni
    Anderson, Kenneth C.
    Moreau, Philippe
    Attal, Michel
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    BLOOD, 2015, 126 (23)
  • [44] Measurable residual disease (MRD)-testing in haematological and solid cancers
    Chen, Junren
    Gale, Robert Peter
    Hu, Yu
    Yan, Wen
    Wang, Tiantian
    Zhang, Wei
    LEUKEMIA, 2024, 38 (06) : 1202 - 1212
  • [45] PROGNOSTIC VALUE OF DEEP SEQUENCING APPROACH FOR MINIMAL RESIDUAL DISEASE (MRD) DETECTION IN MULTIPLE MYELOMA PATIENTS
    Martinez-Lopez, J.
    Lahuerta, J. J.
    Pepin, F.
    Gonzalez, M.
    Barrio, S.
    Ayala, R.
    Puig, N.
    Montalban, M. A.
    Paiva, B.
    Weng, L.
    Jimenez, C.
    Sopena, M.
    Cedena, T.
    Rapado, I.
    Mateo, M. V.
    Rosinol, L.
    Oriol, A.
    Blanchard, M. J.
    Martinez, R.
    Blade, J.
    San Miguel, J.
    Faham, M.
    Garcia-Sanz, R.
    HAEMATOLOGICA, 2014, 99 : 494 - 494
  • [46] A sensitive technique for detection of minimal residual disease (MRD) in myeloma patients
    JeddiTehrani, M
    Gigliotti, D
    Osterborg, A
    Fagerberg, J
    Mellstedt, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 488 - 488
  • [47] MAINTENANCE THERAPY WITH BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA (MM) AFTER ASCT AND MINIMAL RESIDUAL DISEASE (MRD)
    Solovev, M.
    Mendeleeva, L.
    Pokrovskaya, O.
    Gemdzhian, E.
    Galtseva, I.
    Davydova, J.
    Firsova, M.
    Nareyko, M.
    Abramova, T.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 531 - 531
  • [48] Prognostic Value Of Deep Sequencing Approach For Minimal Residual Disease (MRD) Detection In Multiple Myeloma Patients
    Martinez-Lopez, Joaquin
    Laheurta, Juan Jose
    Pepin, Francois
    Gonzalez, Marcos
    Barrio, Santiago
    Ayala, Rosa M.
    Puig, Noemi
    Montalban, Maria Angeles
    Paiva, Bruno
    Weng, Li
    Jimenez, Cristina
    Sopena, Maria
    Cedena, Teresa
    Rapado, Inmaculada
    Mateo, Maria Victoria
    Rosinol, Laura
    Oriol, Albert
    Blanchard, Maria Jesus
    Martinez, Rafael
    Blade, Joan
    San Miguel, Jesus F.
    Faham, Malek
    Garcia-Sanz, Ramon
    BLOOD, 2013, 122 (21)
  • [49] Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic
    Castelli, Germana
    Pelosi, Elvira
    Testa, Ugo
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2021, 57 (04): : 300 - 313
  • [50] Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma
    Paiva, Bruno
    Puig, Noemi
    Cedena, Maria-Teresa
    Rosinol, Laura
    Cordon, Lourdes
    Vidriales, Maria-Belen
    Burgos, Leire
    Flores-Montero, Juan
    Sanoja-Flores, Luzalba
    Lopez-Anglada, Lucia
    Maldonado, Roberto
    de la Cruz, Javier
    Gutierrez, Norma C.
    Calasanz, Maria-Jose
    Martin-Ramos, Maria-Luisa
    Garcia-Sanz, Ramon
    Martinez-Lopez, Joaquin
    Oriol, Albert
    Blanchard, Maria-Jesus
    Rios, Rafael
    Martin, Jesus
    Martinez-Martinez, Rafael
    Sureda, Anna
    Hernandez, Miguel-Teodoro
    de la Rubia, Javier
    Krsnik, Isabel
    Moraleda, Jose-Maria
    Palomera, Luis
    Bargay, Joan
    Van Dongen, Jacques J. M.
    Orfao, Alberto
    Mateos, Maria-Victoria
    Blade, Joan
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (08) : 784 - +